Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years

Tick-borne encephalitis

Prevalence of Tick-borne Encephalitis in the Pediatric Population Treated at the HUS and Characterization of Confirmed Pediatric Cases The Norwegian Tick Born Encephalitis Study Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older Primary TBE Vaccination for the Elderly Application of a TBE-Vaccine in Obese Persons Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 – 67 Years TBE Seropersistence up to 10 Years After First Booster in Adults Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years. Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years. Humoral and Cellular Immunity of Low and High-responders After Tick-borne Encephalitis Vaccination Evaluation of Immunogenicity of Different Tick Borne Encephalitis (TBE) Fast Protective Traveler Schemes With Inactivated TBE Whole Virus Vaccine Tick-borne Encephalitis and Positive Borrelial Antibodies Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules Tick-borne Encephalitis and Borrelial Antibodies in Serum Vaccine Study for Tick-Borne Encephalitis Virus (TBEV) Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE Tick-borne Encephalitis and Possible Borrelial Serology Cervicovaginal Immune Responses to 3 Deltoid or Thigh Intramuscular (IM) TicoVac Humoral Response to Tick-borne Encephalitis Vaccine in Elderly New Study – Humoral Response to Tick-borne Encephalitis Vaccine in Elderly Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients